- Home
- ORIC vs JGH Comparison
ORIC vs JGH Comparison
Compare ORIC & JGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- JGH
- Stock Information
- Founded
- ORIC 2014
- JGH 2014
- Country
- ORIC United States
- JGH United States
- Employees
- ORIC N/A
- JGH N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- JGH Investment Managers
- Sector
- ORIC Health Care
- JGH Finance
- Exchange
- ORIC Nasdaq
- JGH Nasdaq
- Market Cap
- ORIC 362.9M
- JGH 295.5M
- IPO Year
- ORIC 2020
- JGH N/A
- Fundamental
- Price
- ORIC $9.35
- JGH $12.60
- Analyst Decision
- ORIC Strong Buy
- JGH
- Analyst Count
- ORIC 8
- JGH 0
- Target Price
- ORIC $18.83
- JGH N/A
- AVG Volume (30 Days)
- ORIC 2.0M
- JGH 73.9K
- Earning Date
- ORIC 08-11-2025
- JGH 01-01-0001
- Dividend Yield
- ORIC N/A
- JGH 9.85%
- EPS Growth
- ORIC N/A
- JGH N/A
- EPS
- ORIC N/A
- JGH N/A
- Revenue
- ORIC N/A
- JGH N/A
- Revenue This Year
- ORIC N/A
- JGH N/A
- Revenue Next Year
- ORIC N/A
- JGH N/A
- P/E Ratio
- ORIC N/A
- JGH N/A
- Revenue Growth
- ORIC N/A
- JGH N/A
- 52 Week Low
- ORIC $3.90
- JGH $10.36
- 52 Week High
- ORIC $14.67
- JGH $12.85
- Technical
- Relative Strength Index (RSI)
- ORIC 62.84
- JGH 49.35
- Support Level
- ORIC $8.85
- JGH $12.55
- Resistance Level
- ORIC $9.54
- JGH $12.75
- Average True Range (ATR)
- ORIC 0.74
- JGH 0.11
- MACD
- ORIC -0.07
- JGH -0.02
- Stochastic Oscillator
- ORIC 50.98
- JGH 28.57
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About JGH Nuveen Global High Income Fund of Beneficial Interest
Nuveen Global High Income Fund operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of current income. Its securities include U.S. high-yield bonds; non-U.S. high-yield bonds from developed and emerging markets; and other income-producing investments such as preferred and convertible securities.